Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spalt
- Development stage
- Unknown
- Lead developer
- PharmaSGP
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Spalt** is a brand name for over-the-counter pain relief medications primarily marketed in Europe, particularly Germany, for acute mild to moderately severe pain and fever. Different variants contain either a combination of **acetylsalicylic acid (ASA)** and another active ingredient or **ibuprofen** as a single agent, acting as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce pain, inflammation, and fever through inhibition of cyclooxygenase enzymes. It is produced by companies like **PharmaSGP GmbH** and **Pfizer Consumer Healthcare**.
- Brand names
- SpaltSpalt forteSpalt MobilSpalt Headache
- Other names
- SPALT SchmerztablettenSPALT pain pills
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Spalt.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Spalt.